Missing multiple sclerosis medication can be more than a scheduling slip. Doctors say the real danger is that skipped doses can open the door to a relapse, with symptoms that range from dizziness and weakness to vision trouble and other sudden neurologic changes.
Selma Blair’s recent in-flight arrest has pushed that issue into the spotlight because her attorney said she had missed doses of medication used to control severe neurological symptoms. The claim has not been medically confirmed, but it has sparked a familiar question for people living with MS: what actually happens when treatment gets interrupted?
Neurologists say the answer depends on the drug and the person, but the overall message is simple, consistency matters. MS treatment is usually built around keeping the immune system from attacking the nervous system, and when that protection fades, symptoms can come roaring back.
Doctors typically group MS care into a few buckets. Disease-modifying therapies are aimed at lowering relapses and slowing long-term damage, while other drugs are used for flare-ups or for everyday symptoms like fatigue, bladder problems, spasticity, and walking issues.
Those disease-modifying drugs can take several forms, including pills, injections, and IV infusions. Some work by calming immune activity, some block immune cells from reaching the brain and spinal cord, and others remove certain immune cells altogether.
The big goal is keeping the disease quiet for as long as possible. That is why a missed dose can matter, especially when a medication works by constantly holding the immune system in check rather than offering a one-time fix.
Experts say the risk of skipping medication is not the same for every class of drug. Some therapies wear off quickly, while others build up their effects over time, which means the fallout from one missed dose can look very different from one patient to the next.
Still, doctors warn that lapses can raise the odds of relapse, and relapses can come with a rough mix of symptoms. Balance problems, blurred or lost vision, dizziness, weakness, numbness, tingling, or bowel and bladder issues can show up fast and make daily life a mess in a hurry.
That is why new neurologic symptoms after missed medication should not be brushed off. If an MS patient starts feeling off, doctors often want them evaluated quickly to see whether an active flare is underway and whether treatment needs to be restarted or adjusted.
When relapses do happen, high-dose steroids are often used to bring down inflammation and help symptoms improve faster. The catch is that steroids may speed recovery from the flare, but they are not a magic shield against long-term damage.
That makes medication adherence a serious part of the MS playbook. A single delay is not always catastrophic, but repeated missed doses can chip away at disease control and increase the chance of hospitalization or a more intense rebound, especially with certain anti-trafficking drugs.
MS is also known for bringing a grab bag of extra challenges, including depression, fatigue, pain, and bladder trouble. Because so many symptoms can overlap, doctors say it can be hard to tell whether a person is having a flare, dealing with another medical issue, or reacting to missed treatment until they are properly assessed.
For patients and families, the stakes are plain enough. MS management is not just about chasing symptoms after they show up, it is about staying ahead of them, keeping treatment steady, and treating any new neurological changes like something that deserves attention right away.
